Yuan‐Di C. Halvorsen
- Genetics top 0.5%
- Molecular Biology top 10%
- Surgery top 5%
- Physiology top 5%
- Endocrinology, Diabetes and Metabolism top 5%
- Co-authors
- Jeffrey M. GimbleWilliam O. WilkisonDawn M. FranklinXiying WuMason W. FreemanY. Reneé Lea-CurrieAnindita SenEleftherios P. Paschalis
- Topics
- Diabetes Treatment and Management (10 papers)Metabolism, Diabetes, and Cancer (10 papers)Adipose Tissue and Metabolism (8 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Yuan‐Di C. Halvorsen
32 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Genetics 1.1k
- Molecular Biology 980
- Surgery 970
- Physiology 456
- Endocrinology, Diabetes and Metabolism 430
Countries citing papers authored by Yuan‐Di C. Halvorsen
This map shows the geographic impact of Yuan‐Di C. Halvorsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan‐Di C. Halvorsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan‐Di C. Halvorsen more than expected).
Fields of papers citing papers by Yuan‐Di C. Halvorsen
This network shows the impact of papers produced by Yuan‐Di C. Halvorsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan‐Di C. Halvorsen. The network helps show where Yuan‐Di C. Halvorsen may publish in the future.
Co-authorship network of co-authors of Yuan‐Di C. Halvorsen
This figure shows the co-authorship network connecting the top 25 collaborators of Yuan‐Di C. Halvorsen. A scholar is included among the top collaborators of Yuan‐Di C. Halvorsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan‐Di C. Halvorsen. Yuan‐Di C. Halvorsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 9 | |
| 3 | 16 | |
| 4 | Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertensionbreakdown → | 202 |
| 5 | 58 | |
| 6 | 19 | |
| 7 | 32 | |
| 8 | 89 | |
| 9 | 35 | |
| 10 | 88 | |
| 11 | Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis | 2 |
| 12 | Cytokine profile of human adipose‐derived stem cells: Expression of angiogenic, hematopoietic, and pro‐inflammatory factorsbreakdown → | 503 |
| 13 | 14 | |
| 14 | 3 | |
| 15 | 7 | |
| 16 | 63 | |
| 17 | 168 | |
| 18 | 213 | |
| 19 | 165 | |
| 20 | 290 |
About Yuan‐Di C. Halvorsen
Yuan‐Di C. Halvorsen is a scholar working on Otorhinolaryngology, Endocrinology, Diabetes and Metabolism and Genetics, having authored 32 papers that have together received 2.8k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (10 papers), Metabolism, Diabetes, and Cancer (10 papers) and Adipose Tissue and Metabolism (8 papers). The work is most often cited by research in Genetics (1.1k citations), Endocrinology, Diabetes and Metabolism (430 citations) and Urology (161 citations). Yuan‐Di C. Halvorsen has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Jeffrey M. Gimble, William O. Wilkison, Dawn M. Franklin, Xiying Wu, Mason W. Freeman, Y. Reneé Lea-Currie, Anindita Sen, Eleftherios P. Paschalis, Adele L. Boskey and Farshid Guilak. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.